Aleksander Ferbet
Foot & Ankle Surgery · St. Louis, MONPI 1518539170
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (36.3%), food and beverage and education — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Elite Orthopedics, LLC at 37.4% of the total. 2025 is the largest year on record at $6,479, 2.6 times the $2,470 reported in 2021.
Across 158 payments — averaging $122.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Elite Orthopedics, LLC$7K
- Stryker$6K
- Medical Device Business Services, Inc.$2K
- Treace Medical Concepts, Inc.$2K
- Arthrex$676
- Johnson & Johnson$658
- plus $824 from 8 others
What the payments were for
- Travel & lodging$7,01636%
- Food & beverage$6,33033%
- Education$6,00031%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Elite Orthopedics, LLC | 26 | $7,235 |
| Stryker | 61 | $6,211 |
| Medical Device Business Services, Inc. | 11 | $2,028 |
| Treace Medical Concepts, Inc. | 16 | $1,715 |
| Arthrex | 16 | $676 |
| Johnson & Johnson | 16 | $658 |
| Kerecis Limited | 2 | $275 |
| Linvatec Corporation | 3 | $206 |
| Convatec Inc. | 1 | $127 |
| Smith+Nephew | 2 | $62 |
| Koya Medical, Inc. | 1 | $60 |
| Acumed LLC | 1 | $58 |
| Solventum Corporation | 1 | $17 |
| Melinta Therapeutics, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MOTOBAND$1,236
- SALVATION$991
- Kerecis Omega3 Marigen$960
- LAPIPLASTY SYSTEM 1$765
- HOFFMANN$635
- ORTHOLOC 2 LAPIFUSE$610
- ORTHOLOC 3DI$607
- PROstep$590
- AUGMENT INJECTABLE$446
- CITREFIX$308
- Lapiplasty System$286
- Kerecis Omega3 SurgiClose$275
- INFINITY ADAPTIS$244
- PROSTEP MICA$161
- TMC NANOPLASTY SYSTEM$153
- VA-LCP$144
- Kerecis Omega3 GraftGuide$141
- ALLOGRAFT WEDGE SYSTEM$139
- InnovaMatrix AC$127
- BioBrace 23mm$123
How this compares
$19,346 in reported general payments places this provider in the 80th percentile of 163 foot & ankle surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 12 | $343 |
| Methylprednisolone | 25 | $150 |
| Gabapentin | 18 | $103 |
| Meloxicam | 18 | $51 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in St. Louis
- Jeremy McCormickSaint Louis$1.5M
- Jeffrey JohnsonSaint Louis$944K
- Timothy BadweyKansas City$427K
- Raymond AbdoSaint Louis$251K
- Vincent SollecitoSaint Louis$221K
- Amar PatelLees Summit$203K
- Anthony LombardoBridgeton$132K
- Jason AndersonKansas City$131K
- John HoltzmanSaint Louis$129K
- Jesse WolfeSaint Louis$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.